GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sotac Pharmaceuticals SOTAC.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

130.00

—

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹969.9m

FY2020FY2025

Net income

₹80.3m

FY2020FY2025

Free cash flow

−₹213.5m

FY2020FY2025

Shareholders' equity

₹532.5m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue₹969.9m₹1.04bn₹579.8m₹731.5m₹488.4m₹286.0m
Gross profit₹286.8m₹242.2m₹179.2m₹171.7m₹94.5m₹71.8m
Operating income₹98.1m₹51.8m₹65.8m₹68.4m−₹11.4m₹4.6m
Net income₹80.3m₹35.8m₹45.0m₹28.8m−₹23.7m₹875,000
Diluted earnings per share7.263.244.072.61-2.140.08

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets₹1.24bn₹1.05bn—₹352.5m₹347.0m₹303.8m
Cash and short-term investments₹22.5m₹34.0m—₹276,000₹4.4m₹5.9m
Total liabilities₹710.8m₹601.0m—₹286.3m₹322.0m₹273.2m
Debt₹437.0m₹249.0m—₹73.9m₹171.3m₹134.4m
Shareholders' equity₹532.5m₹453.0m—₹66.2m₹24.9m₹30.6m
Shares outstanding11m11m11m11m11m11m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−₹43.3m−₹161.2m₹85.4m₹63.5m−₹3.1m₹570,000
Capital spending−₹170.2m−₹177.9m−₹70.4m−₹35.0m−₹31.6m−₹98.0m
Free cash flow−₹213.5m−₹339.1m₹14.9m₹28.5m−₹34.7m−₹97.4m

Latest quarters

By quarter end

Mar 2025Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Sept 2022
Revenue₹969.9m₹273.5m₹252.5m₹264.4m₹257.0m₹327.0m₹397.5m
Gross profit₹286.8m₹55.7m₹56.7m₹49.2m₹63.0m₹68.0m₹100.1m
Operating income₹98.0m₹13.7m₹14.7m₹590,000₹21.3m₹12.0m₹25.7m
Net income₹80.3m₹4.2m₹13.5m₹15.0m₹8.8m−₹90,000₹4.7m
Diluted earnings per share7.260.381.221.360.79-0.010.42
Total assets₹1.24bn₹1.16bn—₹1.05bn—₹992.0m₹646.0m
Cash and short-term investments₹15.6m₹5.2m—₹34.2m—₹14.6m₹1.5m
Debt₹329.5m₹114.0m—₹220.1m—₹210.0m₹218.0m
Shareholders' equity₹532.5m₹471.6m—₹452.6m—₹427.0m₹80.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.9%27.7%—
Operating income12.8%84.3%—
Net income40.8%146.9%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.3%26.5%25.6%—
Operating margin7.5%8.6%6.8%—
Net margin5.8%5.7%4.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings16.933.729.0
Price to sales1.41.22.3

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 19 Sept 2025.

FY2026
Paid in the year0.10

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.